Efficacy and tolerability of minocycline for depression: A systematic review and meta-analysis of clinical trials

Journal of Affective Disorders

Volumn 227, Issue , 2018, Pages 219-225

  Rosenblat, Joshua D ^a   McIntyre, Roger S ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Antibiotic; Antidepressant; Bipolar disorder; Immune system; Inflammation; Major depressive disorder; Minocycline

Indexed keywords

MINOCYCLINE; ANTIDEPRESSANT AGENT;

ABDOMINAL PAIN; ANTIDEPRESSANT ACTIVITY; ARTHRALGIA; DEPRESSION; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEVER; HUMAN; HYPERPIGMENTATION; HYPOMANIA; META ANALYSIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SWELLING; SYSTEMATIC REVIEW; URTICARIA; CLINICAL TRIAL (TOPIC);

ANTIDEPRESSIVE AGENTS; CLINICAL TRIALS AS TOPIC; DEPRESSION; HUMANS; MINOCYCLINE;

EID: 85032678088     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2017.10.042     Document Type: Review

References (20)

1. Dean, O.M., Kanchanatawan, B., Ashton, M., Mohebbi, M., Ng, C.H., Maes, M., Berk, L., Sughondhabirom, A., Tangwongchai, S., Singh, A.B., Mckenzie, H., Smith, D.J., Malhi, G.S., Dowling, N., Berk, M., Adjunctive minocycline treatment for major depressive disorder: a proof of concept trial. Aust. N.Z. J. Psychiatry 51 (2017), 829–840.
2. Egger, M., Smith, G.D., Phillips, A.N., Meta-analysis: principles and procedures. BMJ 315 (1997), 1533–1537.
3. Emadi-Kouchak, H., Mohammadinejad, P., Asadollahi-Amin, A., Rasoulinejad, M., Zeinoddini, A., Yalda, A., Akhondzadeh, S., Therapeutic effects of minocycline on mild-to-moderate depression in HIV patients: a double-blind, placebo-controlled, randomized trial. Int. Clin. Psychopharmacol. 31 (2016), 20–26.
4. Gaynes, B.N., Warden, D., Trivedi, M.H., Wisniewski, S.R., Fava, M., Rush, A.J., What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression. Psychiatr. Serv. 60 (2009), 1439–1445.
5. Higgins, J.P., Thompson, S.G., Deeks, J.J., Altman, D.G., Measuring inconsistency in meta-analyses. BMJ 327 (2003), 557–560.
6. Husain, M.I., Chaudhry, I.B., Husain, N., Khoso, A.B., Rahman, R.R., Hamirani, M.M., Hodsoll, J., Qurashi, I., Deakin, J.F., Young, A.H., Minocycline as an adjunct for treatment-resistant depressive symptoms: a pilot randomised placebo-controlled trial. J. Psychopharmacol., 2017 (269881117724352).
7. Husain, M.I., Strawbridge, R., Stokes, P.R., Young, A.H., Anti-inflammatory treatments for mood disorders: systematic review and meta-analysis. J. Psychopharmacol., 2017 (269881117725711).
8. Kohler, O., Benros, M.E., Nordentoft, M., Farkouh, M.E., Iyengar, R.L., Mors, O., Krogh, J., Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials. JAMA Psychiatry, 2014.
9. Levine, J., Cholestoy, A., Zimmerman, J., Possible antidepressant effect of minocycline. Am. J. Psychiatry, 153, 1996, 582.
10. Miller, A.H., Maletic, V., Raison, C.L., Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol. Psychiatry 65 (2009), 732–741.
11. Miyaoka, T., Wake, R., Furuya, M., Liaury, K., Ieda, M., Kawakami, K., Tsuchie, K., Taki, M., Ishihara, K., Araki, T., Horiguchi, J., Minocycline as adjunctive therapy for patients with unipolar psychotic depression: an open-label study. Prog. Neuropsychopharmacol. Biol. Psychiatry 37 (2012), 222–226.
12. Raison, C.L., Rutherford, R.E., Woolwine, B.J., Shuo, C., Schettler, P., Drake, D.F., Haroon, E., Miller, A.H., A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry 70 (2013), 31–41.
13. Rapaport, M.H., Nierenberg, A.A., Schettler, P.J., Kinkead, B., Cardoos, A., Walker, R., Mischoulon, D., Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study. Mol. Psychiatry 21 (2016), 71–79.
14. Rosenblat, J.D., Cha, D.S., Mansur, R.B., Mcintyre, R.S., Inflamed moods: a review of the interactions between inflammation and mood disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry 53 (2014), 23–34.
15. Rosenblat, J.D., Kakar, R., Berk, M., Kessing, L.V., Vinberg, M., Baune, B.T., Mansur, R.B., Brietzke, E., Goldstein, B.I., Mcintyre, R.S., Anti-inflammatory agents in the treatment of bipolar depression: a systematic review and meta-analysis. Bipolar Disord. 18 (2016), 89–101.
16. Rosenblat, J.D., Mcintyre, R.S., Bipolar disorder and inflammation. Psychiatr. Clin. N. Am. 39 (2016), 125–137.
17. Soczynska, J.K., Kennedy, S.H., Alsuwaidan, M., Mansur, R.B., Li, M., Mcandrews, M.P., Brietzke, E., Woldeyohannes, H.O., Taylor, V.H., Mcintyre, R.S., A pilot, open-label, 8-week study evaluating the efficacy, safety and tolerability of adjunctive minocycline for the treatment of bipolar I/II depression. Bipolar Disord. 19 (2017), 198–213.
18. Soczynska, J.K., Mansur, R.B., Brietzke, E., Swardfager, W., Kennedy, S.H., Woldeyohannes, H.O., Powell, A.M., Manierka, M.S., Mcintyre, R.S., Novel therapeutic targets in depression: minocycline as a candidate treatment. Behav. Brain Res. 235 (2012), 302–317.
19. Solmi, M., Veronese, N., Thapa, N., Facchini, S., Stubbs, B., Fornaro, M., Carvalho, A.F., Correll, C.U., Systematic review and meta-analysis of the efficacy and safety of minocycline in schizophrenia. CNS Spectr., 2017, 1–12.
20. WHO, 2017. World Health Organization (WHO) Depression Fact Sheet.